Bill > AB916

This bill establishes the Safer Soap Act, which prohibits the manufacture, sale, distribution, or offer for sale of consumer hand soaps and body washes containing specific antimicrobial chemicals (benzalkonium chloride, benzethonium chloride, and chloroxylenol) starting January 1, 2028. The legislation is driven by scientific evidence suggesting these chemicals pose health risks, contribute to antimicrobial resistance, and provide no additional benefits over regular soap. Manufacturers will be required to register with the Department of Toxic Substances Control by July 1, 2028, providing product details, a registration fee, and a compliance statement. The department will develop regulations for implementation, create a Safer Soap Act Fund, and have the authority to issue violations and assess penalties of at least $10,000 for non-compliance. The bill does not apply to products used in healthcare facilities and allows the Attorney General to seek court injunctions against violators. The legislation aims to protect public health, particularly children, by removing potentially harmful antimicrobial chemicals from everyday personal care products, especially given the lack of evidence supporting their effectiveness and potential long-term risks.